PROTOCOL OUTLINE: This is a randomized, double blind study. Patients are stratified by type
Patients are randomly assigned to oral thalidomide or placebo. Therapy is administered
daily for up to 8 weeks, beginning the night before antitubercular treatment is initiated.
Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment
United States: Federal Government